Development and validation of survival nomograms in elder triple-negative invasive ductal breast carcinoma patients

References

• Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Cserni G. Histological type and typing of breast carcinomas and the WHO classification changes over time. Pathologica. 2020;112(1):25–41. doi: 10.32074/1591-951X-1-20
   PubMed Web of Science ®Google Scholar
• Borri F, Granaglia A. Pathology of triple negative breast cancer. Semin Cancer Biol. 2021;72:136–145. doi: 10.1016/j.semcancer.2020.06.005
   PubMed Web of Science ®Google Scholar
• Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747–752. doi: 10.1038/35021093
   PubMed Web of Science ®Google Scholar
• de Boer LL, Kho E, Van de Vijver KK, et al. Optical tissue measurements of invasive carcinoma and ductal carcinoma in situ for surgical guidance. Breast Cancer Res. 2021 May 22;23(1):59. doi: 10.1186/s13058-021-01436-5
   PubMed Web of Science ®Google Scholar
• Chagpar AB, Killelea BK, Tsangaris TN, et al. A randomized, controlled trial of cavity shave margins in breast cancer. N Engl J Med. 2015;373(6):503–510. doi: 10.1056/NEJMoa1504473
   PubMed Web of Science ®Google Scholar
• Yin L, Duan JJ, Bian XW, et al. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 2020 Jun 9;22(1):61. doi: 10.1186/s13058-020-01296-5
   PubMed Web of Science ®Google Scholar
• Howard FM, Olopade OI. Epidemiology of triple-negative breast cancer: a review. Cancer J. 2021;27(1):8–16. doi: 10.1097/PPO.0000000000000500
   PubMed Web of Science ®Google Scholar
• Lyons TG. Targeted therapies for Triple-Negative breast cancer. Curr Treat Options Oncol. 2019 Nov 21;20(11):82. doi: 10.1007/s11864-019-0682-x
   PubMed Web of Science ®Google Scholar
• Kwapisz D. Pembrolizumab and atezolizumab in triple-negative breast cancer. Cancer Immunol Immunother. 2021;70(3):607–617. doi: 10.1007/s00262-020-02736-z
   PubMed Web of Science ®Google Scholar
• Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321(3):288–300. doi: 10.1001/jama.2018.19323
   PubMed Web of Science ®Google Scholar
• Yin Y, Yan Y, Fan B, et al. Novel combination therapy for Triple-Negative breast cancer based on an intelligent hollow carbon Sphere. Research (Wash D C). 2023 Apr 11;6:0098.
   PubMedGoogle Scholar
• Bianchini G, Balko JM, Mayer IA, et al. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13(11):674–690. doi: 10.1038/nrclinonc.2016.66
   PubMed Web of Science ®Google Scholar
• Luo SP, Wu QS, Chen H, et al. Validation of the prognostic significance of the prognostic stage group according to the eighth edition of American cancer joint committee on cancer staging system in triple-negative breast cancer: an analysis from surveillance, epidemiology, and end results 18 database. J Surg Res. 2020;247:211–219. doi: 10.1016/j.jss.2019.09.072
   PubMed Web of Science ®Google Scholar
• Rey-Vargas L, Sanabria-Salas MC, Fejerman L, et al. Risk factors for triple-negative breast cancer among latina women. Cancer Epidemiol Biomarkers Prev. 2019;28(11):1771–1783. doi: 10.1158/1055-9965.EPI-19-0035
   PubMed Web of Science ®Google Scholar
• Polley MC, Leon-Ferre RA, Leung S, et al. A clinical calculator to predict disease outcomes in women with triple-negative breast cancer. Breast Cancer Res Treat. 2021;185(3):557–566. doi: 10.1007/s10549-020-06030-5
   PubMed Web of Science ®Google Scholar
• Coughlin SS. Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat. 2019;177(3):537–548. doi: 10.1007/s10549-019-05340-7
   PubMed Web of Science ®Google Scholar
• Serenari M, Han KH, Ravaioli F, et al. A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma. J Hepatol. 2020;73(4):855–862. doi: 10.1016/j.jhep.2020.04.032
   PubMed Web of Science ®Google Scholar
• Shariat SF, Karakiewicz PI, Suardi N, et al. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res. 2008;14(14):4400–4407. doi: 10.1158/1078-0432.CCR-07-4713
   PubMed Web of Science ®Google Scholar
• Lu J, Xu BB, Zheng CH, et al. Development and external validation of a nomogram to predict recurrence-free survival after R0 resection for stage II/III gastric cancer: an international multicenter study. Front Oncol. 2020 Oct 22;10:574611.
   PubMed Web of Science ®Google Scholar
• Wang S, Yang L, Ci B, et al. Development and validation of a nomogram prognostic model for SCLC patients. J Thorac Oncol. 2018;13(9):1338–1348. doi: 10.1016/j.jtho.2018.05.037
   PubMed Web of Science ®Google Scholar
• Yu C, Zhang Y. Development and validation of prognostic nomogram for young patients with gastric cancer. Ann Transl Med. 2019;7(22):641. doi: 10.21037/atm.2019.10.77
   PubMed Web of Science ®Google Scholar
• Tang JY, Gao HJ, Shi GD, et al. Development and validation of a nomogram prognostic model for patients with neuroendocrine tumors of the thymus. Thorac Cancer. 2020;11(9):2457–2464. doi: 10.1111/1759-7714.13556
   PubMed Web of Science ®Google Scholar
• Portet S. A primer on model selection using the akaike information criterion. Infect Dis Model. 2020 Jan 7;5:111–128. doi:10.1016/j.idm.2019.12.010
   PubMedGoogle Scholar
• Grant SW, Hickey GL, Head SJ. Statistical primer: multivariable regression considerations and pitfalls. Eur J Cardiothorac Surg. 2019;55(2):179–185. doi: 10.1093/ejcts/ezy403
   PubMed Web of Science ®Google Scholar
• Sadatsafavi M, Gustafson P, Zafari Z, et al. Relative impact characteristic curve: a graphical tool to visualize and quantify the clinical utility and population-level consequences of implementing markers. Ann Epidemiol. 2018;28(10):717–723.e3. doi: 10.1016/j.annepidem.2018.07.014
   PubMed Web of Science ®Google Scholar
• Kohl M, Stepath M, Bracht T, et al. CalibraCurve: a tool for calibration of targeted MS-Based measurements. Proteomics. 2020;20(11):e1900143. doi: 10.1002/pmic.201900143
   PubMed Web of Science ®Google Scholar
• Thomas LE, O’Brien EC, Piccini JP, et al. Application of net reclassification index to non-nested and point-based risk prediction models: a review. Eur Heart J. 2019;40(23):1880–1887. doi: 10.1093/eurheartj/ehy345
   PubMed Web of Science ®Google Scholar
• Pencina MJ, Fine JP, RB D Sr. Discrimination slope and integrated discrimination improvement - properties, relationships and impact of calibration. Stat Med. 2017;36(28):4482–4490. doi: 10.1002/sim.7139
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Holland F. Decision curve analysis to evaluate the clinical benefit of prediction models. Spine J. 2021;21(10):1643–1648. doi: 10.1016/j.spinee.2021.02.024
   PubMed Web of Science ®Google Scholar
• Ogłuszka M, Orzechowska M, Jędroszka D, et al. Evaluate cutpoints: adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator. Comput Methods Programs Biomed. 2019;177:133–139. doi: 10.1016/j.cmpb.2019.05.023
   PubMed Web of Science ®Google Scholar
• Cserni G, Chmielik E, Cserni B, et al. The new TNM-based staging of breast cancer. Virchows Arch. 2018;472(5):697–703. doi: 10.1007/s00428-018-2301-9
   PubMed Web of Science ®Google Scholar
• Hardy D, Du DY. Socioeconomic and racial disparities in cancer stage at diagnosis, tumor size, and clinical outcomes in a large cohort of women with breast cancer, 2007–2016. J Racial Ethn Health Disparities. 2021;8(4):990–1001. doi: 10.1007/s40615-020-00855-y
   PubMed Web of Science ®Google Scholar
• Zheng S, Zou Y, Xie X, et al. Development and validation of a stromal immune phenotype classifier for predicting immune activity and prognosis in triple-negative breast cancer. Int J Cancer. 2020;147(2):542–553. doi: 10.1002/ijc.33009
   PubMed Web of Science ®Google Scholar
• Wang X, Xu Y, Guo S, et al. T1-2N1M0 triple-negative breast cancer patients from the SEER database showed potential benefit from post-mastectomy radiotherapy. Oncol Lett. 2020;19(1):735–744. doi: 10.3892/ol.2019.11139
   PubMed Web of Science ®Google Scholar
• Chen H, Yan L, Pu S, et al. Research on effectiveness of prior cancer on survival outcomes for patients with Nonmetastatic Triple-Negative breast cancer: a competing risk analysis and propensity score matching analysis of the SEER database. J Oncol. 2021 Sep 17;2021:9988624. doi:10.1155/2021/9988624
   PubMed Web of Science ®Google Scholar
• Chen SS, Tang SC, Li K, et al. Predicting the survival of triple-negative breast cancer in different stages: a SEER population based research referring to clinicopathological factors. Cancer Invest. 2020;38(10):549–558. doi: 10.1080/07357907.2020.1831010
   PubMed Web of Science ®Google Scholar
• Zhu M, Liang C, Zhang F, et al. A nomogram to predict disease-free survival following neoadjuvant chemotherapy for triple negative breast cancer. Front Oncol. 2021 Oct 21;11:690336.
   PubMedGoogle Scholar
• Xia B, Wang H, Wang Z, et al. A combined nomogram Model to predict disease-free survival in triple-negative breast cancer patients with neoadjuvant chemotherapy. Front Genet. 2021 Nov 12;12:783513.
   PubMed Web of Science ®Google Scholar
• Lin Y, Fu F, Lin S, et al. A nomogram prediction for the survival of patients with triple negative breast cancer. Oncotarget. 2018 Aug 14;9(63):32108–32118. doi: 10.18632/oncotarget.24964
   PubMedGoogle Scholar
• Jing N, Ma MW, Gao XS, et al. Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma. Ann Transl Med. 2020;8(21):1447. doi: 10.21037/atm-20-413
   PubMed Web of Science ®Google Scholar
• Dai D, Jin H, Wang X. Nomogram for predicting survival in triple-negative breast cancer patients with histology of infiltrating duct carcinoma: a population-based study. Am J Cancer Res. 2018 Aug 1;8(8):1576–1585.
   PubMed Web of Science ®Google Scholar